Leukaemia

1. To plan personalised treatment for each individual patient as every individual is different even if they have the same type of cancer.
2. To improve health related quality of life (QOL) in all types and stages of cancer patients.
3. To plan for partial or total regression of tumour depending on the nature of tumors.
4. To increase overall survival (OS) of patients.
5. To increase disease free survival (DFS) where complete resection of tumour is achieved.
6. To provide a treatment option to patients who are refractory to conventional treatments like chemotherapy / radiotherapy / immunotherapy etc.
7. To reduce the rate of growth of the tumor in recurrent and advanced staged cases.
8. To increase progression free survival in advance cases.
9. To reduce impact of symptoms related to progression of disease.
10. To improve confidence of patients.
11. To provide palliative support in end-of- life cancer cases.
12. To add happiness and extension of life to cancer patients.
13. To compliment other therapies like chemotherapy, radiotherapy in a synergistic way.
14. To reduce severity or adverse effects of other conventional treatment. This reduces incidence and frequency of hospitalization.

1. It is pertinent to note that Rasayu Cancer Clinic does not claim or blame anything while communicating any aspect to cancer patients.
2. Rasayu Cancer Clinic focuses on Ayurveda fundamental based therapies.
3. Rasayu Cancer Clinic believes in continuous improvement in service and science.
4. Rasayu Cancer Clinic always advocates patient centric approach which leads to long and happy life of cancer patients.
5. Every patient has a right to choose the therapy.
6. Rasayu Cancer Clinic never imposes Rasayana therapy on patients but helps them to take the right decision, hence making patients/ relatives well aware about the disease and possible outcomes along with its risk benefit and cost benefit ratios.
7. Rasayu Cancer Clinic is well connected with global updates in cancer care and therapies, through advisors and collaborations with national and international institutes.

1. The objective of treatment for Leukaemia is to destroy the Leukaemia cells.
2. Allow normal cells to form in bone marrow.
3. Treatment decisions are based on the kind of Leukaemia, its stage and age and general health of the patient.
   
   

Acute Lymphoid Leukaemia

1. Chemo Therapy, also called induction therapy, kills Leukaemia cells in the blood and bone marrow to induce remission. Treatments include chemotherapy and corticosteroids.
2. Consolidation Therapy kills any Leukaemia cells that may be present even though they do not show up in tests. If these cells regrow, they could cause a relapse. Treatments include more chemotherapy and may include stem cell transplant.
3. Maintenance Therapy is given to prevent residual Leukaemia cells from growing. This may be done using lower doses of chemotherapy than those used during induction or consolidation.
4. Chemotherapy is given with pills and once-a-month intravenous treatment. Maintenance is often continued for up to 3 years.
5. Side Effects of conventional treatment in Leukaemia – Click Here
6. Side effects of Chemotherapy – Click Here
7. Adverse drug reactions (ADRs) of Chemotherapy – Click Here
   
   

Acute Myeloid Leukaemia

1. Induction of Remission kills Leukaemia Cells in the blood and bone marrow to induce remission. Chemotherapy is given by intravenous (IV) treatment. Induction usually lasts 4 weeks, with a week of chemotherapy and then 3 weeks for bone marrow recovery.
2. Post-Remission Therapy kills any Leukaemia cells that may be present even though they don’t show up in tests. This therapy may involve getting additional chemotherapy or a stem cell transplant.
3. For subtype of AML called acute promyelocytic leukaemia, other medicines, such as arsenic trioxide and all-trans retinoic acid (ATRA) can be given.

Chronic Lymphoid Leukaemia

Treatment choices for CLL include :

1. Radiation Therapy may be used to treat Lymph nodes that are swollen from too many abnormal lymphocytes.
2. Chemotherapy is often a combination of medicines and may include monoclonal antibodies.postoperative setting. Indications and technique will depend on anatomical location of the tumor. The major potential advantage of this therapy is functional preservation, particularly of speech and swallowing. Acute skin reactions, mucositis are more common side effects of radiotherapy.

Chronic Myeloid Leukaemia

The most common choices for treatment of CML are:

1. Targeted therapy with a Tyrosine Kinase Inhibitor. This is the first treatment used for CML.
2. Stem Cell Therapy.
3. Side effects of chemotherapy for acute myeloid leukaemia (AML) – Click Here
4. The challenges facing elderly AML treatment – Click Here
5. CAR-T therapy for leukaemia : Progress and Challenges – Click Here

Rasayu Cancer Clinic Rasayan Treatment Protocol – To know more please click here

Rasayu Therapy is recommended for those :

1. Who voluntarily opted for this treatment as their first choice.
2. Who are disenchanted with the past treatments.
3. Who do not see any other options of treatments.
4. Who are looking for personalized treatment plan or precision medicine.
5. Who desire a convenient home-based oral therapy which is easy for consumption.
6. Who are susceptible to acquire hospital borne infections / complications, hence not willing to be hospitalised.
7. Who are looking for favourable risk benefit ratio.
8. Who desire to improve Quality of Life benchmarks based on global standards and monitored regularly.
9. Who wants to be involved in decision making for choice of treatment.
10. Who are willing to be involved in monitoring the efficacy of Rasayana Therapy.
11. Who believe in the transparency of the process by conducting regular investigations by biochemical parameters/ hi tech imaging techniques like PET scan etc.
12. Who are looking for professionals being sensitive to the patient, the care givers and the family.
13. Who desire to take even with other treatments including Chemotherapy / Radiotherapy.